Sign inJoin waitlistJoin the waitlist

Biren Saraiya

Medical Director, Office of Human Research Subjects, Rutgers Cancer Institute · Rutgers Health

Credentials: · · · · ·

History

Office of Human Research Subjects · Rutgers Health
Present
Rutgers Health
Present
Rutgers Health
Present

Rutgers Robert Wood Johnson Medical School
2005–2008
Internal Medicine
2002–2005
Rutgers, Robert Wood Johnson Medical School
1998–2002

Research

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Journal of Clinical Oncology · 2020 · 110 citations
Discussing prognosis: balancing hope and realism
Review · The Cancer Journal · 2010 · 67 citations
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Molecular Cancer Therapeutics · 2023 · 44 citations

Tina Mayer
16 papers
Eric Singer
11 papers
Thomas Jang
11 papers
Saum Ghodoussipour
10 papers · 2 as a fellow
Paul Duberstein
8 papers
AS
Arnav Srivastava
7 papers · 5 as a resident
Isaac Kim
7 papers
Brian Shinder
6 papers · 6 as a resident
Ryan Stephenson
6 papers
Hiren Patel
5 papers · 2 as a resident
Joshua Sterling
5 papers · 5 as a resident
Lara Hathout
5 papers

Clinical trials

Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study
Principal investigator · Completed
Rutgers, The State University of New Jersey
2022–2024
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
Principal investigator · Completed · Phase 1
Rutgers, The State University of New Jersey
2017–2022
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
Principal investigator · Terminated · Phase 2
Rutgers, The State University of New Jersey
2015–2019
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Principal investigator · Completed · Phase 2
Rutgers, The State University of New Jersey
2008–2018